Evidence map›Paper›PMID 26568979›Full record

ArticleData in brief2015

Data from a cross-sectional study on Apolipoprotein E (APOE-ε4) and snoring/sleep apnea in non-demented older adults.

Angeliki Tsapanou, Nikolaos Scarmeas, Yian Gu, Jennifer Manly, Nicole Schupf, Yaakov Stern, Sandra Barral

Open access · goldAbstract read
In one paragraph

Article in Data in brief, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Key variants via the Alzheimer's Disease Sequencing Project whole genome sequence data.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Angeliki TsapanouCognitive Neuroscience Division, Columbia University Medical Center, New York, USA ; National and Kapodistrian University of Athens Medical School, Greece.
Nikolaos ScarmeasCognitive Neuroscience Division, Columbia University Medical Center, New York, USA ; The Department of Neurology, College of Physicians and Surgeons, Columbia University Medical Center, New York, USA ; National and Kapodistrian University of Athens Medical School, Greece.
Yian GuCognitive Neuroscience Division, Columbia University Medical Center, New York, USA ; The Gertrude H. Sergievsky Center, Columbia University Medical Center, New York, USA.
Jennifer ManlyCognitive Neuroscience Division, Columbia University Medical Center, New York, USA ; The Gertrude H. Sergievsky Center, Columbia University Medical Center, New York, USA ; The Department of Neurology, College of Physicians and Surgeons, Columbia University Medical Center, New York, USA.
Nicole SchupfCognitive Neuroscience Division, Columbia University Medical Center, New York, USA ; The Gertrude H. Sergievsky Center, Columbia University Medical Center, New York, USA ; The Department of Neurology, College of Physicians and Surgeons, Columbia University Medical Center, New York, USA.
Yaakov SternCognitive Neuroscience Division, Columbia University Medical Center, New York, USA ; The Gertrude H. Sergievsky Center, Columbia University Medical Center, New York, USA ; The Department of Neurology, College of Physicians and Surgeons, Columbia University Medical Center, New York, USA.
Sandra BarralThe Gertrude H. Sergievsky Center, Columbia University Medical Center, New York, USA.
Columbia University Irving Medical Center · USNational and Kapodistrian University of Athens · GR

Funding

PREDICTORS OF SEVERITY IN ALZHEIMERS DISEASER01AG007370 · NIA · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI STERN, YAAKOV · 1989 to 2021
$16.6M
Dietary Factors and Neuroimaging MarkersK99AG042483 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GU, YIAN · 2013 to 2014
$202k
NIA NIH HHS K99 AG042483NIA NIH HHS R01 AG007370
6 · The paper itself

Abstract

In the present data, we provide the details of the cross-sectional study, from the Washington Heights-Inwood Community Aging Project (WHICAP) that examined the association between Apolipoprotein E (APOE-ε4) and snoring/sleep apnea. A total of 1944 non-demented older adults constituted our sample. Sleep dysfunction was measured using sleep categories derived from the Medical Outcomes Study Sleep Scale. Stratified analyses were conducted in order to examine the association between APOE-ε4 and sleep variables by ethnic group. For further analyses and enhanced discussion, see "Examining the association between Apolipoprotein E (APOE) and self-reported sleep disturbances in non-demented older adults" by Tsapanou et al. (2015) [1].

Indexed as

Apolipoprotein EElderlySleep apneaSnoring

Identifiers

PMID26568979
PMCPMC4602351
OpenAlexW1774411640

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.